Cargando…

Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study

BACKGROUND: We aimed to prospectively assess the lung fibrotic-like changes, as well as to explore their predictive factors, in the patients who survived Coronavirus Disease 2019 (COVID-19) infection. In this prospective cross-sectional study, we recruited patients who had been treated for moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabahati, Mehrdad, Ebrahimpour, Soheil, Khaleghnejad Tabari, Reza, Mehraeen, Rahele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491185/
http://dx.doi.org/10.1186/s43055-021-00632-9
_version_ 1784578692177985536
author Nabahati, Mehrdad
Ebrahimpour, Soheil
Khaleghnejad Tabari, Reza
Mehraeen, Rahele
author_facet Nabahati, Mehrdad
Ebrahimpour, Soheil
Khaleghnejad Tabari, Reza
Mehraeen, Rahele
author_sort Nabahati, Mehrdad
collection PubMed
description BACKGROUND: We aimed to prospectively assess the lung fibrotic-like changes, as well as to explore their predictive factors, in the patients who survived Coronavirus Disease 2019 (COVID-19) infection. In this prospective cross-sectional study, we recruited patients who had been treated for moderate or severe COVID-19 pneumonia as inpatients and discharged from Rohani hospital in Babol, northern Iran, during March 2020. The clinical severity of COVID-19 pneumonia was classified as per the definition by World Health Organization. We also calculated the CT severity score (CSS) for all patients at admission. Within the 3 months of follow-up, the next chest CT scan was performed. As the secondary outcome, the patients with fibrotic abnormalities in their second CT scan were followed up in the next 3 months. RESULTS: Totally, 173 COVID-19 patients were finally included in the study, of whom 57 (32.9%) were male and others were female. The mean age was 53.62 ± 13.67 years old. At 3-month CT follow-up, evidence of pulmonary fibrosis was observed in 90 patients (52.0%). Consolidation (odds ratio [OR] = 2.84), severe disease (OR 2.40), and a higher CSS (OR 1.10) at admission were associated with increased risk of fibrotic abnormalities found at 3-month CT follow-up. Of 62 patients who underwent chest CT scan again at 6 months of follow-up, 41 patients (66.1%) showed no considerable changes in the fibrotic findings, while the rest of 21 patients (33.9%) showed relatively diminished lung fibrosis. CONCLUSION: Post-COVID-19 lung fibrosis was observed in about half of the survivors. Also, patients with severe COVID-19 pneumonia were at a higher risk of pulmonary fibrosis. Moreover, consolidation, as well as a higher CSS, in the initial chest CT scan, was associated with increased risk of post-COVID-19 lung fibrosis. In addition, some patients experienced diminished fibrotic abnormalities in their chest CT on 6-month follow-up, while some others did not.
format Online
Article
Text
id pubmed-8491185
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-84911852021-10-05 Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study Nabahati, Mehrdad Ebrahimpour, Soheil Khaleghnejad Tabari, Reza Mehraeen, Rahele Egypt J Radiol Nucl Med Research BACKGROUND: We aimed to prospectively assess the lung fibrotic-like changes, as well as to explore their predictive factors, in the patients who survived Coronavirus Disease 2019 (COVID-19) infection. In this prospective cross-sectional study, we recruited patients who had been treated for moderate or severe COVID-19 pneumonia as inpatients and discharged from Rohani hospital in Babol, northern Iran, during March 2020. The clinical severity of COVID-19 pneumonia was classified as per the definition by World Health Organization. We also calculated the CT severity score (CSS) for all patients at admission. Within the 3 months of follow-up, the next chest CT scan was performed. As the secondary outcome, the patients with fibrotic abnormalities in their second CT scan were followed up in the next 3 months. RESULTS: Totally, 173 COVID-19 patients were finally included in the study, of whom 57 (32.9%) were male and others were female. The mean age was 53.62 ± 13.67 years old. At 3-month CT follow-up, evidence of pulmonary fibrosis was observed in 90 patients (52.0%). Consolidation (odds ratio [OR] = 2.84), severe disease (OR 2.40), and a higher CSS (OR 1.10) at admission were associated with increased risk of fibrotic abnormalities found at 3-month CT follow-up. Of 62 patients who underwent chest CT scan again at 6 months of follow-up, 41 patients (66.1%) showed no considerable changes in the fibrotic findings, while the rest of 21 patients (33.9%) showed relatively diminished lung fibrosis. CONCLUSION: Post-COVID-19 lung fibrosis was observed in about half of the survivors. Also, patients with severe COVID-19 pneumonia were at a higher risk of pulmonary fibrosis. Moreover, consolidation, as well as a higher CSS, in the initial chest CT scan, was associated with increased risk of post-COVID-19 lung fibrosis. In addition, some patients experienced diminished fibrotic abnormalities in their chest CT on 6-month follow-up, while some others did not. Springer Berlin Heidelberg 2021-10-05 2021 /pmc/articles/PMC8491185/ http://dx.doi.org/10.1186/s43055-021-00632-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Nabahati, Mehrdad
Ebrahimpour, Soheil
Khaleghnejad Tabari, Reza
Mehraeen, Rahele
Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study
title Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study
title_full Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study
title_fullStr Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study
title_full_unstemmed Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study
title_short Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study
title_sort post-covid-19 pulmonary fibrosis and its predictive factors: a prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491185/
http://dx.doi.org/10.1186/s43055-021-00632-9
work_keys_str_mv AT nabahatimehrdad postcovid19pulmonaryfibrosisanditspredictivefactorsaprospectivestudy
AT ebrahimpoursoheil postcovid19pulmonaryfibrosisanditspredictivefactorsaprospectivestudy
AT khaleghnejadtabarireza postcovid19pulmonaryfibrosisanditspredictivefactorsaprospectivestudy
AT mehraeenrahele postcovid19pulmonaryfibrosisanditspredictivefactorsaprospectivestudy